Fulgent Genetics (FLGT) Interest & Investment Income (2018 - 2026)

Fulgent Genetics has disclosed Interest & Investment Income across 9 years of filings, most recently posting $6.4 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 20.85% year-over-year to $6.4 million; the TTM figure through Jun 2026 stood at $29.9 million (down 7.6% YoY), while the FY2025 annual figure was $30.9 million, down 1.23% from the prior year.
• Interest & Investment Income came in at $6.4 million for Q2 2026 at Fulgent Genetics, down from $8.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $8.7 million in Q1 2026 to a low of $45000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $5.8 million, with a median of $6.7 million recorded in 2023.
• The largest YoY upside for Interest & Investment Income was 9288.57% in 2022 against a maximum downside of 84.04% in 2022.
• Over 5 years, Interest & Investment Income stood at $3.2 million in 2022, then jumped by 80.66% to $5.8 million in 2023, then jumped by 39.81% to $8.1 million in 2024, then dropped by 14.61% to $6.9 million in 2025, then slipped by 7.67% to $6.4 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $6.4 million in Q2 2026, $8.7 million in Q1 2026, and $6.9 million in Q4 2025.